APO-LAMIVUDINE

Resumen del producto

About APO-LAMIVUDINE

APO-LAMIVUDINE is a prescription medication containing the active ingredient LAMIVUDINE, a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of human immunodeficiency virus (HIV) infection and chronic hepatitis B (HBV) infection.

Key Benefits & Uses

• Treatment of HIV infection in combination with other antiretroviral agents.
• Treatment of chronic hepatitis B infection in adults with evidence of active viral replication and either evidence of liver damage or elevated liver enzymes.
• Prevention of mother-to-child transmission of HIV.

Active Ingredient & Action

LAMIVUDINE works by inhibiting the replication of HIV and HBV viruses by interfering with the viral DNA synthesis. It is phosphorylated to its active triphosphate form, which competes with the natural nucleoside triphosphates for incorporation into viral DNA, resulting in chain termination and inhibition of viral replication.

Important Notes

APO-LAMIVUDINE is available in tablet form for oral administration. It is essential to follow the prescribed dosage and treatment regimen to achieve optimal therapeutic effects. Patients with pre-existing liver disease or kidney impairment should be closely monitored during treatment. Concomitant use with other medications may require dose adjustments or increased monitoring. Consult a healthcare professional for more information and to discuss potential side effects and interactions.